Torcetrapib and atherosclerosis: what happened and where do we go from here?

Author： Toth Peter P  

Publisher： Future Medicine

ISSN： 1746-0875

Source： Future Lipidology, Vol.2, Iss.3, 2007-06, pp. : 277-284

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antibiotic resistance: what have we learned and where do we go from here?

By Blondeau Joseph  

Therapy, Vol. 3, Iss. 6, 2006-11 ,pp. : 751-753

Future Medicine

Access to resources Recommend Favorite

Infant body composition in the PEA POD® era: what have we learned and where do we go from here?

By  

Journal of Developmental Origins of Health and Disease, Vol. 4, Iss. 2, 2012-11 ,pp. : 116-120

Cambridge University Press

Access to resources Recommend Favorite

Where do we go from here? Caring versus the system

By Jeffs Stanley  

British Journal of General Practice, Vol. 63, Iss. 614, 2013-09 ,pp. : 490-490

Royal College of General Practitioners

Access to resources Recommend Favorite

Pre-empting breast cancer: where do we go from here?

By Chlebowski Rowan T  

Women's Health, Vol. 4, Iss. 2, 2008-03 ,pp. : 113-114

Future Medicine

Access to resources Recommend Favorite

Medical Futility: Where Do We Go from Here?

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 42, Iss. 8, 1994-08 ,pp. : 904-905

John Wiley & Sons Inc

Access to resources Recommend Favorite